Old Web
English
Sign In
Acemap
>
authorDetail
>
Yunming Mu
Yunming Mu
AbbVie
Internal medicine
Medicine
in patient
Bortezomib
Dexamethasone
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
2020
Blood
Paul G. Richardson
Akshanth R. Polepally
Monica Motwani
Yunming Mu
Zeena Salman
Sudhir Penugonda
Philippe Moreau
Show All
Source
Cite
Save
Citations (1)
AML-058: First-In-Human Study of a Trail Receptor Agonist Fusion Protein, Eftozanermin Alfa, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Diffuse Large B-Cell Lymphoma
2020
Clinical Lymphoma, Myeloma & Leukemia
Mojca Jongen-Lavrencic
Junichiro Yuda
Rogier Mous
Adam J. Olszewski
Marcel Nijland
Sameem Abedin
Emiliano Calvo
Silpa Nuthalapati
Monica Motwani
Dimple A. Modi
Yunming Mu
Adam M. Petrich
Sudhir Penugonda
Daniel Morillo
Show All
Source
Cite
Save
Citations (1)
1